Long-term outcome after placement of a percutaneous endoscopic gastrostomy tube

Geriatrics & Gerontology International
Takanari TokunagaToshio Gotoh

Abstract

To evaluate long-term survival and prognostic factors in patients who have undergone placement of a percutaneous endoscopic gastrostomy tube. A retrospective analysis of all patients without malignancy who underwent percutaneous endoscopic gastrostomy at Hanyu General Hospital during the period January 2001-December 2005. A total of 198 patients (100 men, 98 women) were assessed. Median age was 78 years (range, 25-97 years). The primary diagnosis was a cerebrovascular disorder in 149 (75.3%) of the patients. Prior to placement, 120 (60.6%) had suffered pneumonia. Survival was 87.4% at 1 month, 67.8% at 3 months, 52.6% at 6 months, 38.1% at 1 year, 27.8% at 2 years and 22.3% at 3 years. Pneumonia was the most common cause of death during the follow-up period (91 of 140 patients, 65.0%). Cox's proportional hazards model showed independent predictors of mortality to be a low serum albumin concentration (<or=2.9 g/dL) and history of pneumonia before the procedure. Mortality of patients who underwent percutaneous endoscopic gastrostomy appears to be high. In particular, the long-term prognosis was poor for patients with hypoalbuminemia, and this procedure is probably not preferred for patients with recurrent aspiration pneumonia.

References

Nov 23, 1996·Lancet·T E Finucane, J P Bynum
Jun 27, 1998·JAMA : the Journal of the American Medical Association·M D GrantJ A Brody
Jul 14, 2000·The American Journal of Gastroenterology·D S SandersK D Bardhan
Mar 3, 2001·The New England Journal of Medicine·P E Marik
May 26, 2004·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Galia AbuksisYaron Niv
Jun 16, 2005·Journal of Gastroenterology and Hepatology·Ahmet ErdilKemal Dagalp

❮ Previous
Next ❯

Citations

Nov 26, 2010·Journal of Gastroenterology and Hepatology·Hiroyuki ImaedaToshifumi Hibi
Nov 5, 2010·Internal Medicine·Naoyuki TominagaKazuma Fujimoto
Apr 3, 2012·Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics·Eiichi Sudo, Hiroo Hanabusa
Sep 21, 2013·Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics·Yukimasa Igawa, Izumi Matsubara
Oct 27, 2010·World Journal of Gastroenterology : WJG·Yutaka SuzukiMitsuyoshi Urashima
Dec 12, 2012·ISRN Gastroenterology·Fabrizio Cardin
May 4, 2013·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Matthew KurienDavid S Sanders
Apr 23, 2013·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Gaurav AroraSamir Gupta
Feb 5, 2014·Chest·Christopher GilbertLonny Yarmus
Jul 16, 2010·Journal of the American Medical Directors Association·Krishna P Aparanji, T S Dharmarajan
Jan 14, 2012·Geriatrics & Gerontology International·Yoichi KosakaHidetada Sasaki
Jan 1, 2014·Geriatrics & Gerontology International·Ana Olivia Cortés-FloresAlejandro González-Ojeda
Jun 15, 2010·Gastrointestinal Endoscopy·Richard S KwonWilliam M Tierney
Dec 30, 2014·Scandinavian Journal of Gastroenterology·Marianne UddLeena Kylänpää
Jan 1, 2012·International Journal of Immunopathology and Pharmacology·M MegnaM Ranieri
Oct 5, 2017·Journal of the American Geriatrics Society·Marzena GieniuszGisele Wolf-Klein
Jul 4, 2015·World Journal of Gastroenterology : WJG·Kazuyuki MatsumotoKazuhide Yamamoto
Aug 14, 2021·The Cochrane Database of Systematic Reviews·Nathan DaviesElizabeth L Sampson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.